BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 30623525)

  • 1. Age-related survival disparity in stage IB and IIB cervical cancer patients.
    Sakakibara A; Matsui K; Katayama T; Higuchi T; Terakawa K; Konishi I
    J Obstet Gynaecol Res; 2019 Mar; 45(3):686-694. PubMed ID: 30623525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and pathological factors related to the prognosis of chinese patients with stage Ib to IIb cervical cancer.
    Xie XZ; Song K; Cui B; Jiang J; Zhang YZ; Wang B; Yang XS; Kong BH
    Asian Pac J Cancer Prev; 2012; 13(11):5505-10. PubMed ID: 23317208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the prognosis between adenocarcinoma and squamous cell carcinoma in stage IB-IIA cervical cancer.
    Xie X; Song K; Cui B; Jiang J; Yang X; Kong B
    Int J Clin Oncol; 2018 Jun; 23(3):522-531. PubMed ID: 29299705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High dose-rate brachytherapy for elderly patients with uterine cervical cancer.
    Chen SW; Liang JA; Yang SN; Lin FJ
    Jpn J Clin Oncol; 2003 May; 33(5):221-8. PubMed ID: 12865465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postoperative radiotherapy for uterine cervical cancer: impact of lymph node and histological type on survival.
    Kasuya G; Ogawa K; Iraha S; Nagai Y; Hirakawa M; Toita T; Kakinohana Y; Kudaka W; Inamine M; Ariga T; Aoki Y; Murayama S
    Anticancer Res; 2013 May; 33(5):2199-204. PubMed ID: 23645776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant therapy after radical surgery for stage IB-IIB cervical adenocarcinoma with risk factors.
    Seki T; Tanabe H; Nagata C; Suzuki J; Suzuki K; Takano H; Isonishi S; Ochiai K; Takakura S; Okamoto A
    Jpn J Clin Oncol; 2017 Jan; 47(1):32-38. PubMed ID: 27677664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome of international Federation of gynecology and obstetrics stage IIb cervical cancer from 2003 to 2012: an evaluation of treatments and prognosis: a retrospective study.
    Guo L; Liu X; Wang L; Sun H; Huang K; Li X; Tang F; Li S; Yuan X; Wang C
    Int J Gynecol Cancer; 2015 Jun; 25(5):910-8. PubMed ID: 25867278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognosis and clinicopathological characteristics of Ib-IIb adenocarcinoma of the uterine cervix in patients who have had radical hysterectomy.
    Irie T; Kigawa J; Minagawa Y; Itamochi H; Sato S; Akeshima R; Terakawa N
    Eur J Surg Oncol; 2000 Aug; 26(5):464-7. PubMed ID: 11016467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathologic Factors of Cervical Adenocarcinoma Stages IB to IIB.
    Mabuchi Y; Yahata T; Kobayashi A; Tanizaki Y; Shiro M; Ota N; Yagi S; Minami S; Ino K
    Int J Gynecol Cancer; 2015 Nov; 25(9):1677-82. PubMed ID: 26495760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-risk human papillomavirus status and prognosis in invasive cervical cancer: A nationwide cohort study.
    Lei J; Ploner A; Lagheden C; Eklund C; Nordqvist Kleppe S; Andrae B; Elfström KM; Dillner J; Sparén P; Sundström K
    PLoS Med; 2018 Oct; 15(10):e1002666. PubMed ID: 30273338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of prognoses of pathologic stage Ib adenocarcinoma and squamous cell carcinoma of the uterine cervix.
    Nakanishi T; Ishikawa H; Suzuki Y; Inoue T; Nakamura S; Kuzuya K
    Gynecol Oncol; 2000 Nov; 79(2):289-93. PubMed ID: 11063659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the addition of concurrent chemotherapy to pelvic radiotherapy in surgically treated stage IB1-IIB cervical cancer patients with intermediate-risk or high-risk factors: a 13-year experience.
    Okazawa M; Mabuchi S; Isohashi F; Suzuki O; Yoshioka Y; Sasano T; Ohta Y; Kamiura S; Ogawa K; Kimura T
    Int J Gynecol Cancer; 2013 Mar; 23(3):567-75. PubMed ID: 23385284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is neoadjuvant chemotherapy followed by radical surgery more effective than radiation therapy for stage IIB cervical cancer?
    Lee DW; Lee KH; Lee JW; Park ST; Park JS; Lee HN
    Int J Gynecol Cancer; 2013 Sep; 23(7):1303-10. PubMed ID: 23881101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of pretreatment 18F-fluorodeoxyglucose uptake in patients with cervical cancer treated with definitive chemoradiotherapy.
    Onal C; Reyhan M; Parlak C; Guler OC; Oymak E
    Int J Gynecol Cancer; 2013 Jul; 23(6):1104-10. PubMed ID: 23792605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretreatment Mean Apparent Diffusion Coefficient Is Significantly Correlated With Event-Free Survival in Patients With International Federation of Gynecology and Obstetrics Stage Ib to IIIb Cervical Cancer.
    Himoto Y; Fujimoto K; Kido A; Baba T; Tanaka S; Morisawa N; Koyasu S; Konishi I; Togashi K
    Int J Gynecol Cancer; 2015 Jul; 25(6):1079-85. PubMed ID: 25853385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of any impact of histopathology type on prognosis in patients with early-stage adenocarcinoma and squamous cell carcinoma of the uterine cervix.
    Teke F; Yoney A; Teke M; Inal A; Urakci Z; Eren B; Zincircioglu SB; Buyukpolat MY; Ozer A; Isikdogan A; Unsal M
    Asian Pac J Cancer Prev; 2014; 15(6):2815-9. PubMed ID: 24761906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of the absolute number and ratio of metastatic lymph nodes in predicting postoperative survival for the International Federation of Gynecology and Obstetrics stage IA2 to IIA cervical cancer.
    Chen Y; Zhang L; Tian J; Fu X; Ren X; Hao Q
    Int J Gynecol Cancer; 2013 Jan; 23(1):157-63. PubMed ID: 23221732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus and prognosis of invasive cervical cancer: a population-based study.
    Schwartz SM; Daling JR; Shera KA; Madeleine MM; McKnight B; Galloway DA; Porter PL; McDougall JK
    J Clin Oncol; 2001 Apr; 19(7):1906-15. PubMed ID: 11283122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Results of different postoperative adjuvant therapies for stage Ib-IIa cervical carcinoma with risk factors].
    Wen HW; Huang WP; Liu TY; Ma K; Tao X; Zhu LR; Liao QP
    Zhonghua Fu Chan Ke Za Zhi; 2013 Dec; 48(12):920-4. PubMed ID: 24495686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is there really a difference in survival of women with squamous cell carcinoma, adenocarcinoma, and adenosquamous cell carcinoma of the cervix?
    Shingleton HM; Bell MC; Fremgen A; Chmiel JS; Russell AH; Jones WB; Winchester DP; Clive RE
    Cancer; 1995 Nov; 76(10 Suppl):1948-55. PubMed ID: 8634986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.